Armistice Capital »

Dermata Therapeutics shares owned by Armistice Capital

Quarter-by-quarter ownership of Dermata Therapeutics (DRMA) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Dermata Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dermata Therapeutics held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dermata Therapeutics by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $67k 28k 2.39

More positions owned by Armistice Capital

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Incyte Corporation (INCY)
Immunovant (IMVT)
Travere Therapeutics (TVTX)
Agios Pharmaceuticals (AGIO)
Grifols S A Sp Adr Rep B Nvt (GRFS)
Argenx Se Sponsored Adr (ARGX)
Inari Medical Ord (NARI)
Anheuser Busch Inbev Sa Sponsored Adr (BUD)
Dentsply Sirona (XRAY)
Novo-nordisk A S Adr (NVO)

View all positions for Armistice Capital

Top funds holding Dermata Therapeutics

Tower Research Capital
Wells Fargo & Company
UBS Group
Bank of America Corporation

View all funds holding Dermata Therapeutics